Whittenburg Mark G

CNM General Counsel Whittenburg sells 50,000 shares for $3.0M at $60.03; holds 9.7K post-transaction after derivative conversion.

Whittenburg executed 2 separate sales totaling 50,000 shares (50.0K shares) for $3,001,255.09 ($3.0M) at $60.03 on June 6 and June 9, reducing his shareholding from 59.7K shares to 9.7K shares post-transaction (a reduction of -83.8%). This filing involves a derivative-conversion transaction, so the Table I holdings shown do not represent his total economic position; derivative holdings remain in Table II and are not yet available in our database. At CNM specifically, Whittenburg's 5 prior sales all showed negative 90-day returns, meaning he has sold at opportune moments before subsequent declines—a 100% well-timed rate at this ticker. The stock has gained 12.5% over the prior 30 days and 22.2% over 90 days, currently trading at $58.10, near its 52-week high of $59.68. CNM's fundamentals show stable strength: $1.9B quarterly revenue, $100.0M quarterly net income, and 11.0% annual revenue growth, with a P/E of 27.15. The material scale of this sale and the insider's consistent pattern of well-timed exits at this specific ticker merit investor attention, though the derivative-conversion nature of the filing means the full economic picture cannot be assessed without Table II data.

CNM General Counsel Whittenburg sold 50,000 shares across 2 transactions (Jan 15-16) for $2,756,793.14 at blended average $55.14

Mark G Whittenburg, General Counsel and Secretary, executed two separate sales totaling 50,000 (50.0K shares) for $2,756,793.14 on 2025-01-15 and 2025-01-16 at prices of $55.29 and $55.13 respectively (blended average $55.14). The sales reduced his holdings from 57,667 to 7,667 shares (-86.7% reduction). This is a derivative-conversion transaction with Table II derivative holdings not yet populated in the database, so the reported 7,667 shares do not represent his complete position. Over his cross-ticker history, Whittenburg's 3 prior sells show a 90-day well-timed rate of 100.00%, and his prior 2 sales at CNM specifically were both well-timed at the 90-day mark (posts-sale declines of -4.5% and -11.7%). The current stock price of $55.22 is 11.0% below the 52-week high of $62.03, with positive recent momentum (+9.9% over 30 days, +18.2% over 90 days). The company's fundamentals show modest growth (revenue $2.0B, annual growth +0.8%) and a P/E of 25.68.

General Counsel Mark Whittenburg sold 50,000 shares of CNM at $50.49 on 2025-01-10; holds 7,667 shares post-transaction via derivative conversion.

Mark Whittenburg, General Counsel and Secretary, sold 50,000 shares at $50.49 on 2025-01-10, reducing his direct holdings from 57,667 to 7,667 shares (an 86.7% reduction in common shares), while maintaining derivative positions not yet fully reflected in available database records. The sale occurred at $50.49 against a current price of $53.95, meaning the transaction price was 6.4% below today's market level. His cross-ticker track record shows strong sell-timing discipline with a 90-day well-timed rate of 100.00%, though his same-ticker history at CNM is mixed: two prior sells on 2024-04-19 and 2024-03-22 both achieved negative 90-day returns (−4.5% and −11.7% respectively), indicating he has previously exited ahead of declines at this company. The current P/E of 25.09 alongside minimal annual revenue growth of +0.8% suggests a mature valuation environment where insider reduction of common shares may warrant investor attention, particularly given the derivative-conversion context of this filing.